Lv31
350 积分 2023-05-24 加入
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
5天前
已完结
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis
17天前
已完结
TYK2 inhibition with deucravacitinib ameliorates erosive oral lichen planus
28天前
已完结
Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs)
28天前
已完结
TYK2: an emerging therapeutic target in rheumatic disease
28天前
已完结
Recommendations for Broadening Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials
30天前
已完结
Recommendations for New Trials of Currently Available Therapy by the IOIBD Task Force on Clinical Trials*
30天前
已完结
IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus
30天前
已完结
Risk Factors for the Development of Psoriasis
1个月前
已完结
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version)
1个月前
已完结
皖公网安备34019202002308
